Advanced in Neurotoxicity Syndromes

Claire Roddie

Queen Square, 
London, ENG, GB 
Advanced in Neurotoxicity Syndromes
Queen Square, 
London, ENG, GB 
OverviewLocationsClinical Research

Overview

Claire Roddie practices in London, United Kingdom. Ms. Roddie is rated as an Advanced expert by MediFind in the treatment of Neurotoxicity Syndromes. Her top areas of expertise are B-Cell Lymphoma, Non-Hodgkin Lymphoma, Acute Lymphoblastic Leukemia (ALL), Neurotoxicity Syndromes, and Bone Marrow Transplant.

Her clinical research consists of co-authoring 84 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 6 articles in the study of Neurotoxicity Syndromes.

Gender
Female

Locations

Queen Square, London, ENG, United Kingdom
Other Locations
UCLH
London, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

An Open-Label, Multi-Centre, Phase Ib/II Study Evaluating the Safety and Efficacy of AUTO1, a CAR T Cell Treatment Targeting CD19, in Adult Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukaemia
An Open-Label, Multi-Centre, Phase Ib/II Study Evaluating the Safety and Efficacy of AUTO1, a CAR T Cell Treatment Targeting CD19, in Adult Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukaemia
Enrollment Status: Active_not_recruiting
Publish Date: September 09, 2025
Intervention Type: Biological
Study Drugs: Cyclophosphamide, Fludarabine, CD19-Positive CAR-T Cells
Study Phase: Phase 1/Phase 2

84 Total Publications

To c or not to c-KIT?: High toxicity and modest efficacy in CD117-directed CAR T cell therapy.
To c or not to c-KIT?: High toxicity and modest efficacy in CD117-directed CAR T cell therapy.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: September 08, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Roddie's expertise for a condition
ConditionClose
    View All 17 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile